English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jun 30, 2026

Report finds many pharmaceutical ingredients can be replaced with PFAS-free alternatives
+ Pharmaceuticals
Patient Daily | Jun 30, 2026

FDA rejects Unicycive and Sobi filings over contract manufacturing deficiencies
+ Pharmaceuticals
Patient Daily | Jun 30, 2026

Columbia team reveals moving junction’s active role in malaria parasite invasion
+ Pharmaceuticals
Patient Daily | Jun 30, 2026

Review finds high-dose IV vitamin C may lower trauma mortality but evidence remains limited
+ Pharmaceuticals
Patient Daily | Jun 30, 2026

Eli Lilly’s David Ricks tops 2025 pharma CEO compensation rankings
+ Pharmaceuticals
Patient Daily | Jun 30, 2026

SickKids study identifies cell recovery mechanisms linked to stomach cancer risk
+ Pharmaceuticals
Patient Daily | Jun 30, 2026

FDA cell and gene therapy head Vijay Kumar steps down after one year
+ Regulatory
Patient Daily | Jun 30, 2026

AANP welcomes interim guidance on federal student loan access for graduate nursing programs

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation